Clinical Trials Browser

Terminated × Neoplasm Metastasis × Etoposide × Clear all

NCT00810017 2022-05-19

Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

Phase 2 Terminated

2 enrolled 3 charts

Breast Neoplasms, Neoplasm Metastasis